Loading insider details...
Latest Form 4 (Jul 30, 2026): Grant/Award of 756,104 SRPT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 30, 2026 | Sarepta Therapeutics, Inc. (SRPT) | Grant/Award | 756,104 | n/a |
| May 11, 2026 | Avantor, Inc. (AVTR) | Grant/Award | 25,270 | n/a |
| Mar 10, 2026 | Viatris Inc (VTRS) | Exercise/Conversion | 25,112 | n/a |
| May 13, 2025 | Viatris Inc (VTRS) | Grant/Award | 25,112 | n/a |
| May 12, 2025 | Avantor, Inc. (AVTR) | Grant/Award | 17,100 | n/a |
| May 13, 2024 | Avantor, Inc. (AVTR) | Grant/Award | 8,477 | n/a |
| May 15, 2023 | Avantor, Inc. (AVTR) | Grant/Award | 9,808 | n/a |
| May 25, 2022 | AbbVie Inc. (ABBV) | Exercise/Conversion | 46,320 | $5.30M |
| May 18, 2022 | AbbVie Inc. (ABBV) | Exercise/Conversion | 70,879 | $4.35M |
| May 16, 2022 | Avantor, Inc. (AVTR) | Grant/Award | 6,693 | n/a |